Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis
Archives of Microbiology · 2025
DOI: 10.1007/s00203-025-04422-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Min Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Shandong University, Shandong, 250013, China. Hauptthemen laut MEDLINE: Gallic Acid, Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Development Plan of Medicine and Health Science and Technology of Shandong Province.
Abstract (Originalsprache)
The persistent rise of multidrug-resistant (MDR) bacteria represents a significant public health challenge, necessitating the exploration of alternative therapeutic options. The slow pace of approval for new anti-tuberculosis (TB) medications underscores the urgent need to identify potential alternative agents. Gallic acid (GA) possesses numerous biological properties, including antibacterial and antiseptic effects. In this study, both standard and MDR strains of M. tuberculosis were utilized to assess the antibacterial efficacy of GA and related mechanisms. GA achieved minimum inhibitory and minimum bactericidal concentrations comparable to those of the examined antibiotics with significantly lower cytotoxicity in the THLE-3 cell line (p-value < 0.05). Furthermore, GA displayed bactericidal properties, enhanced the effectiveness of moxifloxacin and levofloxacin against MDR M. tuberculosis, and modulated the expression of efflux pump genes, specifically Rv1410c and Rv1258c (p-value < 0.001). These results contribute to a deeper understanding of GA's antibacterial potential and suggest a novel alternative approach for managing MDR bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Shandong University, Shandong, 250013, China.
- Medical Laboratory Department, Amir A'lam Hospital, Tehran, Iran.
- Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Shandong University, Shandong, 250013, China. wp1980jn@sina.com.
Förderung
- Development Plan of Medicine and Health Science and Technology of Shandong Province
Zitieren
APA
Wei, M., Bostani, A., Jamalsi, N., Baqin, H., & Wen, P. (2025). Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04422-z
Vancouver
Wei M, Bostani A, Jamalsi N, Baqin H, Wen P. Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis. Archives of Microbiology. 2025. doi:10.1007/s00203-025-04422-z
BibTeX
@article{Wei2025,
author = {Wei, Min and Bostani, Amirabas and Jamalsi, Nadi and Baqin, Hasan and Wen, Peng},
title = {Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis},
journal = {Archives of Microbiology},
year = {2025},
doi = {10.1007/s00203-025-04422-z}
}
EUVIMED